Zymeworks (ZYME) Misses Q4 EPS by 55c

Zymeworks (NASDAQ: ZYME) reported Q4 EPS of ($0.55). Revenue for the quarter came in at $2.52 million.

For earnings history and earnings-related data on Zymeworks (ZYME) click here.

You May Also Be Interested In

• Spire (SR) Misses Q3 EPS by 6c; offers guidance
• CVS Health (CVS) Tops Q2 EPS by 75c; raises guidance
• Elanco Animal Health (ELAN) Tops Q2 EPS by 7c; offers guidance